MICONAZOLE NITRATE

MICONAZOLE NITRATE was reported 8853 times

MICONAZOLE NITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF GENITALIA 78 0.6393
1 VULVOVAGINAL BURNING SENSATION 1919 0.3141
2 VULVOVAGINAL EXFOLIATION 12 0.2308
3 VAGINAL EROSION 35 0.2244
4 VULVOVAGINAL PAIN 1055 0.2188
5 INFECTIVE CORNEAL ULCER 6 0.2143
6 VULVOVAGINAL SWELLING 325 0.1778
7 VAGINAL MUCOSAL BLISTERING 36 0.1600
8 VULVOVAGINAL INJURY 80 0.1404
9 VULVOVAGINAL ERYTHEMA 115 0.1376
10 VULVOVAGINAL PRURITUS 630 0.1243
11 INFECTIVE KERATITIS 8 0.1127
12 VULVOVAGINAL DISCOMFORT 480 0.1085
13 ENCEPHALITIC INFECTION 4 0.1081
14 VULVOVAGINAL INFLAMMATION 45 0.0976
15 VAGINAL EXFOLIATION 5 0.0962
16 TONGUE NECROSIS 7 0.0959
17 VULVOVAGINAL RASH 31 0.0703
18 ENCEPHALITIS FUNGAL 6 0.0667
19 VAGINAL LACERATION 13 0.0596
20 CHOLESTASIS OF PREGNANCY 26 0.0565
21 PRODUCT USED FOR UNKNOWN INDICATION 66 0.0524
22 PHARYNGEAL HAEMATOMA 6 0.0496
23 VAGINAL SWELLING 17 0.0478
24 CHEMICAL BURN 55 0.0477
25 GENITAL BLISTER 12 0.0433
26 TONGUE HAEMATOMA 7 0.0354
27 GENITAL PARAESTHESIA 10 0.0345
28 GENITAL BURNING SENSATION 19 0.0219
29 OEDEMA GENITAL 13 0.0203
30 VAGINAL LESION 6 0.0196
31 CHEMICAL INJURY 16 0.0196
32 KERATITIS FUNGAL 4 0.0192
33 VAGINAL ULCERATION 8 0.0190
34 VULVAL DISORDER 12 0.0182
35 GENITAL SWELLING 11 0.0159
36 CONGENITAL HYPOTHYROIDISM 4 0.0155
37 VAGINAL BURNING SENSATION 7 0.0149
38 PRODUCT IMPURITY 4 0.0146
39 VAGINAL DISCHARGE 140 0.0138
40 PRIMARY ADRENAL INSUFFICIENCY 4 0.0131
41 GENITAL PRURITUS FEMALE 4 0.0123
42 PERIPHERAL NERVE LESION 4 0.0121
43 VAGINAL HAEMORRHAGE 494 0.0114
44 CORYNEBACTERIUM INFECTION 6 0.0112
45 TOXIC SHOCK SYNDROME 7 0.0111
46 OESOPHAGEAL MOTILITY DISORDER 4 0.0111
47 MESOTHELIOMA MALIGNANT 4 0.0108
48 VAGINAL DISORDER 10 0.0104
49 CHEMICAL BURN OF SKIN 26 0.0102
50 GENITAL ERYTHEMA 5 0.0101
51 INDUCED LABOUR 6 0.0101
52 GENITAL RASH 14 0.0098
53 SKIN CANDIDA 5 0.0096
54 VAGINAL ODOUR 11 0.0087
55 PERINEAL PAIN 6 0.0084
56 ALLERGIC COUGH 6 0.0078
57 PAROTID GLAND ENLARGEMENT 5 0.0077
58 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 5 0.0076
59 VULVOVAGINAL CANDIDIASIS 10 0.0074
60 FUNGAL SEPSIS 6 0.0072
61 APPLICATION SITE WARMTH 9 0.0071
62 JARISCH-HERXHEIMER REACTION 5 0.0070
63 HAEMATOMA INFECTION 4 0.0069
64 NEURAL TUBE DEFECT 5 0.0069
65 CLEFT LIP 6 0.0069
66 GENITAL HYPOAESTHESIA 7 0.0069
67 GENITAL PAIN 10 0.0068
68 VULVOVAGINAL MYCOTIC INFECTION 25 0.0063
69 INTERNATIONAL NORMALISED RATIO INCREASED 178 0.0062
70 HERPES ZOSTER DISSEMINATED 5 0.0062
71 APPLICATION SITE PAIN 137 0.0062
72 VULVOVAGINAL DRYNESS 20 0.0062
73 MESOTHELIOMA 8 0.0062
74 GINGIVAL DISCOMFORT 4 0.0061
75 DEAFNESS TRANSITORY 5 0.0059
76 GRAVITATIONAL OEDEMA 4 0.0058
77 HYDRONEPHROSIS 43 0.0057
78 HAEMORRHAGE SUBCUTANEOUS 20 0.0056
79 BLOODY DISCHARGE 6 0.0052
80 COAGULATION TEST ABNORMAL 4 0.0052
81 ANAPHYLACTOID REACTION 21 0.0051
82 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
83 APPLICATION SITE BURN 24 0.0049
84 PREMATURE LABOUR 27 0.0048
85 APPLICATION SITE SWELLING 23 0.0046
86 TINEA INFECTION 5 0.0045
87 ANOGENITAL WARTS 4 0.0045
88 BACTERIAL VAGINOSIS 7 0.0045
89 CRYPTORCHISM 5 0.0045
90 TINEA PEDIS 7 0.0044
91 ADMINISTRATION SITE PAIN 5 0.0043
92 CHRONIC RESPIRATORY FAILURE 5 0.0041
93 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0040
94 APPLICATION SITE DISCOMFORT 7 0.0039
95 PNEUMOMEDIASTINUM 7 0.0039
96 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
97 SKIN EROSION 11 0.0034
98 VAGINAL INFECTION 16 0.0034
99 ONYCHOMADESIS 14 0.0033
100 APPLICATION SITE HAEMORRHAGE 9 0.0033
101 NEPHROGENIC ANAEMIA 15 0.0032
102 STOMA SITE ERYTHEMA 6 0.0032
103 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
104 ASPERGILLOSIS 4 0.0031
105 CARDIOACTIVE DRUG LEVEL INCREASED 4 0.0030
106 ORAL CANDIDIASIS 39 0.0030
107 TONGUE BITING 6 0.0029
108 LIVE BIRTH 24 0.0029
109 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
110 OEDEMA MOUTH 9 0.0028
111 MATERNAL DRUGS AFFECTING FOETUS 21 0.0027
112 CANCER PAIN 7 0.0027
113 DYSURIA 96 0.0026
114 CUTANEOUS LUPUS ERYTHEMATOSUS 5 0.0026
115 APPLICATION SITE PRURITUS 58 0.0026
116 APLASIA 5 0.0026
117 PRURITUS GENITAL 6 0.0025
118 HEART DISEASE CONGENITAL 9 0.0025
119 FUNGAEMIA 4 0.0025
120 BURNING SENSATION 175 0.0025
121 CANDIDIASIS 10 0.0025
122 FUNGAL SKIN INFECTION 10 0.0025
123 ANAL PRURITUS 5 0.0024
124 HYPERPARATHYROIDISM SECONDARY 6 0.0024
125 ANORECTAL DISCOMFORT 12 0.0023
126 DRUG MONITORING PROCEDURE NOT PERFORMED 4 0.0022
127 HYPERNATRAEMIA 11 0.0022
128 STOMA SITE DISCHARGE 6 0.0022
129 LOBAR PNEUMONIA 4 0.0022
130 JAUNDICE NEONATAL 4 0.0021
131 LACUNAR INFARCTION 5 0.0021
132 NASAL DRYNESS 13 0.0021
133 TONGUE ULCERATION 7 0.0021
134 PNEUMONIA FUNGAL 8 0.0020
135 RETROPERITONEAL HAEMORRHAGE 5 0.0020
136 SUFFOCATION FEELING 5 0.0020
137 FUNGAL INFECTION 67 0.0020
138 THERMAL BURN 14 0.0020
139 EXPIRED PRODUCT ADMINISTERED 65 0.0020
140 VENTRICULAR SEPTAL DEFECT 11 0.0019
141 ATRIAL SEPTAL DEFECT 16 0.0019
142 CONDITION AGGRAVATED 580 0.0019
143 SKIN ABRASION 9 0.0019
144 DRUG INTERACTION 302 0.0019
145 CONJUNCTIVAL HAEMORRHAGE 7 0.0018
146 MACULE 5 0.0018
147 ERYSIPELAS 9 0.0018
148 PRODUCT SOLUBILITY ABNORMAL 9 0.0018
149 CANDIDA INFECTION 30 0.0018
150 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
151 BLOOD LOSS ANAEMIA 4 0.0018
152 OESOPHAGEAL CANDIDIASIS 7 0.0018
153 HAEMATURIA 59 0.0017
154 INGROWING NAIL 4 0.0017
155 HAEMORRHAGIC DIATHESIS 6 0.0017
156 CYTOMEGALOVIRUS INFECTION 28 0.0017
157 GESTATIONAL DIABETES 8 0.0017
158 GRAFT VERSUS HOST DISEASE 12 0.0017
159 HUMERUS FRACTURE 8 0.0017
160 STILLBIRTH 8 0.0017
161 REBOUND ACID HYPERSECRETION 5 0.0017
162 BREATH ODOUR 4 0.0016
163 EXPIRED DRUG ADMINISTERED 8 0.0016
164 HYPERACUSIS 6 0.0016
165 ECCHYMOSIS 11 0.0016
166 DECUBITUS ULCER 13 0.0016
167 EXCORIATION 4 0.0016
168 SCREAMING 10 0.0016
169 STUPOR 5 0.0016
170 FAILURE TO THRIVE 8 0.0015
171 URINE ODOUR ABNORMAL 9 0.0015
172 ODYNOPHAGIA 9 0.0015
173 HAEMATOMA 39 0.0015
174 PROTHROMBIN TIME PROLONGED 9 0.0015
175 DERMATITIS ACNEIFORM 9 0.0015
176 EYE MOVEMENT DISORDER 10 0.0015
177 PRODUCT USE COMPLAINT 23 0.0015
178 REGURGITATION 5 0.0015
179 APPLICATION SITE IRRITATION 18 0.0014
180 DRUG ADMINISTERED AT INAPPROPRIATE SITE 15 0.0014
181 APPLICATION SITE REACTION 10 0.0014
182 NECROTISING FASCIITIS 5 0.0014
183 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
184 GLOSSITIS 5 0.0014
185 ABSCESS LIMB 6 0.0014
186 OESOPHAGEAL STENOSIS 4 0.0014
187 PULMONARY HAEMORRHAGE 11 0.0014
188 CONJUNCTIVAL HYPERAEMIA 5 0.0014
189 SKIN WEEPING 5 0.0014
190 RASH PUSTULAR 10 0.0014
191 MOUTH HAEMORRHAGE 10 0.0014
192 STEVENS-JOHNSON SYNDROME 30 0.0013
193 MENINGITIS 9 0.0013
194 PARTIAL SEIZURES 7 0.0013
195 METABOLIC ENCEPHALOPATHY 4 0.0013
196 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
197 HYPERCAPNIA 4 0.0013
198 URINE ABNORMALITY 6 0.0013
199 MICTURITION URGENCY 15 0.0013
200 MEDICAL DEVICE DISCOMFORT 4 0.0013
201 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
202 UNDERDOSE 95 0.0013
203 ACUTE RESPIRATORY FAILURE 25 0.0013
204 DIASTOLIC DYSFUNCTION 4 0.0013
205 PATENT DUCTUS ARTERIOSUS 5 0.0013
206 PNEUMONIA VIRAL 4 0.0013
207 SPINAL OSTEOARTHRITIS 11 0.0013
208 EXPOSURE TO TOXIC AGENT 4 0.0012
209 CUSHINGOID 4 0.0012
210 BLOOD CALCIUM DECREASED 14 0.0012
211 MATERNAL EXPOSURE DURING BREAST FEEDING 5 0.0012
212 FACIAL PAIN 11 0.0012
213 APPLICATION SITE DISCOLOURATION 5 0.0012
214 FULL BLOOD COUNT ABNORMAL 13 0.0012
215 BACTERIAL SEPSIS 4 0.0012
216 MOUTH SWELLING 7 0.0012
217 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
218 END STAGE RENAL DISEASE 22 0.0012
219 RALES 7 0.0012
220 INCORRECT ROUTE OF DRUG ADMINISTRATION 43 0.0012
221 EOSINOPHILIA 21 0.0012
222 PROSTATE CANCER METASTATIC 4 0.0012
223 UROSEPSIS 11 0.0012
224 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
225 ECONOMIC PROBLEM 18 0.0012
226 TOOTH ABSCESS 12 0.0012
227 DRUG EXPOSURE DURING PREGNANCY 40 0.0012
228 PERICARDIAL EFFUSION 27 0.0012
229 CARDIAC MURMUR 10 0.0012
230 ORAL DISCOMFORT 16 0.0012
231 ABDOMINAL PAIN LOWER 29 0.0011
232 DERMATITIS CONTACT 13 0.0011
233 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
234 RESPIRATORY RATE INCREASED 10 0.0011
235 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
236 MONOCYTE COUNT INCREASED 4 0.0011
237 SALIVARY HYPERSECRETION 11 0.0011
238 FAECALOMA 6 0.0011
239 SENSITIVE SKIN 8 0.0011
240 APPLICATION SITE VESICLES 7 0.0011
241 SPINAL COLUMN STENOSIS 5 0.0011
242 FACE INJURY 4 0.0011
243 MOUTH ULCERATION 22 0.0010
244 PRODUCT ADMINISTRATION ERROR 21 0.0010
245 AGRANULOCYTOSIS 19 0.0010
246 HYPOKALAEMIA 47 0.0010
247 CELLULITIS 51 0.0010
248 BLOOD CREATININE INCREASED 66 0.0010
249 TRICUSPID VALVE INCOMPETENCE 8 0.0010
250 HYPERLIPIDAEMIA 12 0.0010
251 DERMATITIS 21 0.0010
252 GANGRENE 6 0.0010
253 SCAR 17 0.0010
254 PRODUCT PHYSICAL ISSUE 20 0.0010
255 LIP DRY 9 0.0010
256 ADRENAL INSUFFICIENCY 12 0.0010
257 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
258 ADVERSE REACTION 13 0.0010
259 PERIPHERAL VENOUS DISEASE 4 0.0010
260 ORTHOSTATIC HYPOTENSION 17 0.0010
261 HYPERSENSITIVITY 181 0.0010
262 CEREBRAL ISCHAEMIA 5 0.0010
263 CONJUNCTIVITIS 18 0.0010
264 SEPSIS 108 0.0010
265 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
266 TONGUE DISORDER 7 0.0010
267 PREMATURE BABY 29 0.0010
268 BASAL CELL CARCINOMA 15 0.0010
269 ACCIDENTAL EXPOSURE 4 0.0010
270 BLOOD URINE PRESENT 18 0.0009
271 HYPOPHOSPHATAEMIA 7 0.0009
272 DRUG INEFFECTIVE 1241 0.0009
273 ENTERITIS 6 0.0009
274 CHRONIC KIDNEY DISEASE 71 0.0009
275 PROCTALGIA 6 0.0009
276 HEREDITARY ANGIOEDEMA 10 0.0009
277 BREAST CANCER METASTATIC 10 0.0009
278 CHROMATURIA 21 0.0009
279 ANAL ABSCESS 5 0.0009
280 INCORRECT PRODUCT ADMINISTRATION DURATION 20 0.0009
281 SKIN SWELLING 8 0.0009
282 PHARYNGEAL SWELLING 9 0.0009
283 BLOOD CALCIUM INCREASED 8 0.0009
284 ONYCHOMYCOSIS 4 0.0009
285 RENAL FAILURE CHRONIC 7 0.0009
286 STAPHYLOCOCCAL INFECTION 30 0.0009
287 PRODUCT FORMULATION ISSUE 6 0.0009
288 HAEMATEMESIS 23 0.0009
289 SLEEP DISORDER 64 0.0009
290 HYPERKERATOSIS 5 0.0009
291 HYPONATRAEMIA 51 0.0009
292 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
293 HYPOTONIA 9 0.0009
294 CARDIOMEGALY 11 0.0009
295 FLUID OVERLOAD 13 0.0009
296 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
297 SKIN INFECTION 10 0.0009
298 POSTOPERATIVE WOUND INFECTION 6 0.0009
299 EXPOSURE DURING PREGNANCY 55 0.0009
300 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
301 ANHEDONIA 23 0.0009
302 HAEMORRHAGE INTRACRANIAL 13 0.0009
303 MULTI-ORGAN FAILURE 15 0.0009
304 HEPATIC CYTOLYSIS 11 0.0009
305 PETECHIAE 9 0.0009
306 URINARY TRACT INFECTION 147 0.0009
307 PAPULE 6 0.0009
308 ABASIA 21 0.0008
309 DIVERTICULUM 6 0.0008
310 EMBOLISM 7 0.0008
311 RECALLED PRODUCT ADMINISTERED 8 0.0008
312 ATELECTASIS 8 0.0008
313 FOETAL GROWTH RESTRICTION 5 0.0008
314 VITAMIN D DEFICIENCY 8 0.0008
315 OBESITY 13 0.0008
316 SWELLING FACE 53 0.0008
317 BLINDNESS TRANSIENT 6 0.0008
318 BREATH SOUNDS ABNORMAL 4 0.0008
319 LIP SWELLING 27 0.0008
320 ABDOMINAL TENDERNESS 4 0.0008
321 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
322 MALNUTRITION 9 0.0008
323 PROTEIN URINE PRESENT 4 0.0008
324 DERMATITIS EXFOLIATIVE 4 0.0008
325 POLLAKIURIA 33 0.0008
326 MYOCARDIAL ISCHAEMIA 9 0.0008
327 SLEEP APNOEA SYNDROME 15 0.0008
328 WRONG DRUG ADMINISTERED 7 0.0008
329 DRUG LEVEL INCREASED 13 0.0008
330 ABDOMINAL PAIN 182 0.0008
331 INCORRECT DRUG ADMINISTRATION DURATION 22 0.0008
332 RENAL FAILURE ACUTE 33 0.0008
333 PERIPHERAL VASCULAR DISORDER 4 0.0008
334 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
335 ENCEPHALOPATHY 19 0.0008
336 APNOEA 6 0.0008
337 HERPES SIMPLEX 5 0.0008
338 RECTAL HAEMORRHAGE 33 0.0008
339 APLASTIC ANAEMIA 4 0.0008
340 PNEUMONIA BACTERIAL 7 0.0008
341 BACTERAEMIA 9 0.0008
342 IRON DEFICIENCY ANAEMIA 7 0.0008
343 LIVER FUNCTION TEST ABNORMAL 22 0.0008
344 BLOOD ALBUMIN DECREASED 6 0.0008
345 MENTAL STATUS CHANGES 21 0.0008
346 ATRIAL FLUTTER 6 0.0008
347 BLOOD DISORDER 6 0.0007
348 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
349 FLANK PAIN 7 0.0007
350 CHEILITIS 4 0.0007
351 NO THERAPEUTIC RESPONSE 9 0.0007
352 PRODUCT LABEL ISSUE 5 0.0007
353 PRODUCT PACKAGING ISSUE 7 0.0007
354 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 5 0.0007
355 PANCYTOPENIA 41 0.0007
356 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
357 ESCHERICHIA INFECTION 6 0.0007
358 LYMPHOEDEMA 5 0.0007
359 GASTRIC ULCER HAEMORRHAGE 4 0.0007
360 ON AND OFF PHENOMENON 4 0.0007
361 NERVE INJURY 8 0.0007
362 LEUKOCYTOSIS 13 0.0007
363 SKIN FISSURES 14 0.0007
364 PHARYNGEAL OEDEMA 11 0.0007
365 DEVICE RELATED INFECTION 11 0.0007
366 PERICARDITIS 12 0.0007
367 ANGIOPATHY 4 0.0007
368 URINARY INCONTINENCE 21 0.0007
369 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
370 MITRAL VALVE INCOMPETENCE 8 0.0007
371 HYPERTONIA 4 0.0007
372 SKIN ULCER 18 0.0007
373 BLOOD MAGNESIUM DECREASED 6 0.0007
374 BLISTER 39 0.0007
375 HERPES VIRUS INFECTION 4 0.0007
376 CYSTITIS 22 0.0007
377 HYPERVENTILATION 4 0.0007
378 CRYING 25 0.0007
379 MAJOR DEPRESSION 5 0.0007
380 HYPOVOLAEMIA 4 0.0007
381 TOOTH INFECTION 9 0.0007
382 MELAENA 15 0.0007
383 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
384 BLOOD POTASSIUM INCREASED 11 0.0007
385 SKIN IRRITATION 31 0.0007
386 SKIN HAEMORRHAGE 10 0.0007
387 ACUTE KIDNEY INJURY 103 0.0007
388 DISCOMFORT 41 0.0007
389 SCRATCH 7 0.0007
390 PELVIC PAIN 12 0.0007
391 COAGULOPATHY 11 0.0007
392 TROPONIN INCREASED 5 0.0007
393 HAEMATOCRIT DECREASED 13 0.0007
394 INCREASED TENDENCY TO BRUISE 6 0.0007
395 FOOD ALLERGY 5 0.0006
396 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
397 CONGENITAL ANOMALY 5 0.0006
398 PELVIC FRACTURE 5 0.0006
399 ACUTE MYELOID LEUKAEMIA 10 0.0006
400 SWELLING 60 0.0006
401 OESOPHAGITIS 7 0.0006
402 BONE MARROW FAILURE 13 0.0006
403 ARTERIOSCLEROSIS 6 0.0006
404 OSTEOARTHRITIS 27 0.0006
405 MULTIPLE INJURIES 4 0.0006
406 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
407 TOOTH LOSS 13 0.0006
408 HYPOXIA 22 0.0006
409 PULMONARY HYPERTENSION 13 0.0006
410 HYPERCHOLESTEROLAEMIA 6 0.0006
411 SKIN EXFOLIATION 52 0.0006
412 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
413 RENAL TUBULAR NECROSIS 6 0.0006
414 HEPATOMEGALY 6 0.0006
415 RASH PRURITIC 33 0.0006
416 MULTIPLE FRACTURES 10 0.0006
417 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
418 CARDIAC FAILURE ACUTE 4 0.0006
419 PNEUMONIA ASPIRATION 15 0.0006
420 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
421 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
422 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
423 CHOLECYSTITIS CHRONIC 4 0.0006
424 BLOOD UREA INCREASED 10 0.0006
425 POST-TRAUMATIC STRESS DISORDER 4 0.0006
426 UNEVALUABLE EVENT 45 0.0006
427 OSTEOPENIA 9 0.0006
428 CONTUSION 57 0.0006
429 UTERINE PERFORATION 5 0.0006
430 ALANINE AMINOTRANSFERASE INCREASED 36 0.0006
431 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
432 RASH ERYTHEMATOUS 28 0.0006
433 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
434 BLOOD SODIUM DECREASED 11 0.0006
435 PSEUDOMONAS INFECTION 5 0.0006
436 THROMBOCYTOPENIA 65 0.0006
437 HYPOCALCAEMIA 11 0.0006
438 VENTRICULAR EXTRASYSTOLES 6 0.0006
439 PYELONEPHRITIS 5 0.0006
440 PLEURAL EFFUSION 35 0.0006
441 INTENTIONAL DRUG MISUSE 12 0.0006
442 CHOLESTASIS 11 0.0006
443 DEMENTIA 16 0.0006
444 CYANOSIS 9 0.0006
445 CYTOPENIA 7 0.0006
446 CARPAL TUNNEL SYNDROME 8 0.0006
447 SKIN DISORDER 19 0.0006
448 NEUROPATHY PERIPHERAL 54 0.0006
449 PAIN IN JAW 16 0.0006
450 HAEMORRHOIDS 11 0.0006
451 MUSCULAR WEAKNESS 64 0.0006
452 RESPIRATORY FAILURE 41 0.0006
453 RENAL FAILURE 74 0.0006
454 ANAL INCONTINENCE 5 0.0006
455 ATRIAL FIBRILLATION 54 0.0006
456 MYELODYSPLASTIC SYNDROME 8 0.0006
457 DERMATITIS BULLOUS 4 0.0006
458 SKIN LACERATION 6 0.0006
459 SEPTIC SHOCK 24 0.0006
460 OPTIC NEURITIS 5 0.0005
461 MATERNAL EXPOSURE DURING PREGNANCY 49 0.0005
462 HYPERGLYCAEMIA 20 0.0005
463 GASTROENTERITIS 8 0.0005
464 SKIN LESION 15 0.0005
465 GENITAL HAEMORRHAGE 7 0.0005
466 RESPIRATORY DISTRESS 15 0.0005
467 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
468 MEDICAL DEVICE COMPLICATION 4 0.0005
469 ARTHROPOD BITE 4 0.0005
470 RASH MACULO-PAPULAR 12 0.0005
471 FEELING DRUNK 4 0.0005
472 HEPATIC STEATOSIS 10 0.0005
473 IMMUNODEFICIENCY 8 0.0005
474 PULMONARY CONGESTION 7 0.0005
475 STOMATITIS 32 0.0005
476 SPUTUM DISCOLOURED 5 0.0005
477 DYSPHAGIA 50 0.0005
478 SCAB 6 0.0005
479 PRURITUS 201 0.0005
480 SEROTONIN SYNDROME 10 0.0005
481 CHILLS 61 0.0005
482 SEIZURE 60 0.0005
483 DELIRIUM 18 0.0005
484 MUSCULOSKELETAL CHEST PAIN 8 0.0005
485 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
486 TACHYPNOEA 7 0.0005
487 ACCIDENTAL EXPOSURE TO PRODUCT 53 0.0005
488 IMPAIRED GASTRIC EMPTYING 7 0.0005
489 FEBRILE NEUTROPENIA 34 0.0005
490 SPLENOMEGALY 6 0.0005
491 INFLAMMATORY BOWEL DISEASE 5 0.0005
492 GASTROINTESTINAL INFLAMMATION 4 0.0005
493 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
494 HYPOPHAGIA 13 0.0005
495 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
496 HOSPICE CARE 5 0.0005
497 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
498 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
499 HALLUCINATION, AUDITORY 8 0.0005
500 HAEMOPTYSIS 14 0.0005
501 MUSCLE RIGIDITY 6 0.0005
502 WOUND 14 0.0005
503 SKIN DISCOLOURATION 23 0.0005
504 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
505 SEDATION 13 0.0005
506 DRUG EFFECT INCOMPLETE 18 0.0005
507 URTICARIA 83 0.0005
508 MYASTHENIA GRAVIS 4 0.0005
509 CONSTIPATION 108 0.0005
510 PULMONARY OEDEMA 22 0.0005
511 ASPHYXIA 4 0.0005
512 PANCREATITIS ACUTE 11 0.0005
513 PARALYSIS 7 0.0005
514 CONFUSIONAL STATE 79 0.0005
515 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 99 0.0005
516 METASTASES TO BONE 8 0.0005
517 PHARYNGITIS 6 0.0005
518 BLOOD BILIRUBIN INCREASED 13 0.0005
519 HEMIPLEGIA 4 0.0005
520 THROAT TIGHTNESS 13 0.0005
521 LYMPHADENOPATHY 17 0.0005
522 TENDERNESS 5 0.0005
523 HAEMORRHAGE 50 0.0005
524 ANAEMIA 91 0.0005
525 CEREBRAL HAEMORRHAGE 17 0.0005
526 ANGIOEDEMA 21 0.0005
527 INFUSION SITE ERYTHEMA 4 0.0005
528 PRODUCT COMPLAINT 12 0.0005
529 INCONTINENCE 5 0.0005
530 CONVULSION 27 0.0005
531 RENAL INJURY 14 0.0005
532 INADEQUATE ANALGESIA 4 0.0005
533 PULMONARY MASS 7 0.0005
534 CIRCULATORY COLLAPSE 8 0.0005
535 ROTATOR CUFF SYNDROME 6 0.0005
536 FEELING COLD 13 0.0005
537 BLOOD POTASSIUM DECREASED 14 0.0005
538 DEHYDRATION 62 0.0005
539 PARANOIA 8 0.0005
540 PHARYNGITIS STREPTOCOCCAL 5 0.0005
541 OSTEOPOROSIS 19 0.0005
542 TACHYCARDIA 41 0.0005
543 MUCOSAL INFLAMMATION 12 0.0005
544 APPLICATION SITE ERYTHEMA 12 0.0005
545 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
546 PRODUCT COMMUNICATION ISSUE 4 0.0005
547 DENTAL CARIES 5 0.0005
548 EAR INFECTION 12 0.0005
549 URINARY RETENTION 15 0.0004
550 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
551 ABORTION SPONTANEOUS 18 0.0004
552 CYTOKINE RELEASE SYNDROME 9 0.0004
553 ERYTHEMA 92 0.0004
554 GLOSSODYNIA 10 0.0004
555 ORAL PAIN 10 0.0004
556 HAEMOLYTIC ANAEMIA 4 0.0004
557 HAEMARTHROSIS 4 0.0004
558 MYOSITIS 4 0.0004
559 INTESTINAL PERFORATION 5 0.0004
560 OEDEMA PERIPHERAL 54 0.0004
561 EYE INFECTION 5 0.0004
562 PAIN 271 0.0004
563 INJURY 31 0.0004
564 PALLOR 12 0.0004
565 PNEUMONITIS 12 0.0004
566 SCIATICA 7 0.0004
567 SPEECH DISORDER 23 0.0004
568 EXOSTOSIS 4 0.0004
569 MYOCARDITIS 5 0.0004
570 INTENTIONAL PRODUCT MISUSE 38 0.0004
571 APHASIA 13 0.0004
572 EYE SWELLING 16 0.0004
573 COGNITIVE DISORDER 20 0.0004
574 DRUG RESISTANCE 11 0.0004
575 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
576 LACERATION 4 0.0004
577 RASH GENERALISED 11 0.0004
578 OEDEMA 23 0.0004
579 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
580 FRACTURE 8 0.0004
581 SINUS TACHYCARDIA 6 0.0004
582 PLATELET COUNT DECREASED 45 0.0004
583 RASH 184 0.0004
584 IMPAIRED WORK ABILITY 9 0.0004
585 FOETAL EXPOSURE DURING PREGNANCY 34 0.0004
586 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
587 DRUG PRESCRIBING ERROR 8 0.0004
588 SWOLLEN TONGUE 13 0.0004
589 PARAESTHESIA ORAL 6 0.0004
590 EPISTAXIS 31 0.0004
591 NOCTURIA 5 0.0004
592 CARDIAC FAILURE CONGESTIVE 33 0.0004
593 AUTOIMMUNE DISORDER 4 0.0004
594 OXYGEN SATURATION DECREASED 23 0.0004
595 JAUNDICE 11 0.0004
596 BACK PAIN 94 0.0004
597 GENERALISED OEDEMA 5 0.0004
598 PRODUCT USE IN UNAPPROVED INDICATION 100 0.0004
599 INABILITY TO AFFORD MEDICATION 4 0.0004
600 HERPES ZOSTER 23 0.0004
601 HEPATIC ENZYME INCREASED 27 0.0004
602 PYREXIA 137 0.0004
603 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
604 DRUG ERUPTION 7 0.0004
605 DEVICE FAILURE 6 0.0004
606 DRUG LEVEL DECREASED 4 0.0004
607 ABDOMINAL DISTENSION 41 0.0004
608 NEUTROPHIL COUNT DECREASED 16 0.0004
609 MOTOR DYSFUNCTION 4 0.0004
610 HIP ARTHROPLASTY 6 0.0004
611 SHOCK 9 0.0004
612 DRUG EFFECT DECREASED 21 0.0004
613 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
614 HELICOBACTER INFECTION 4 0.0004
615 GAIT INABILITY 13 0.0004
616 OSTEOMYELITIS 7 0.0004
617 ACCIDENTAL OVERDOSE 14 0.0004
618 PRODUCT ODOUR ABNORMAL 4 0.0004
619 PNEUMOTHORAX 6 0.0004
620 INSOMNIA 100 0.0004
621 IRRITABLE BOWEL SYNDROME 8 0.0004
622 QUALITY OF LIFE DECREASED 5 0.0004
623 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
624 INTERSTITIAL LUNG DISEASE 18 0.0004
625 DECREASED ACTIVITY 4 0.0004
626 PRESYNCOPE 9 0.0004
627 HAEMOGLOBIN DECREASED 38 0.0004
628 PRURITUS GENERALISED 8 0.0004
629 SYNCOPE 37 0.0004
630 DRY MOUTH 30 0.0004
631 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
632 FOOT FRACTURE 7 0.0004
633 ADVERSE DRUG REACTION 33 0.0004
634 DRUG TOXICITY 5 0.0004
635 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
636 LETHARGY 21 0.0004
637 ABDOMINAL PAIN UPPER 75 0.0004
638 PHOTOSENSITIVITY REACTION 6 0.0004
639 DIVERTICULITIS 10 0.0004
640 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 65 0.0004
641 MEDICATION ERROR 20 0.0004
642 ORAL HERPES 7 0.0004
643 COORDINATION ABNORMAL 5 0.0004
644 DIARRHOEA 230 0.0004
645 FACE OEDEMA 6 0.0004
646 DIALYSIS 5 0.0004
647 HEPATITIS 9 0.0004
648 BONE DENSITY DECREASED 11 0.0004
649 ERECTILE DYSFUNCTION 9 0.0004
650 PREGNANCY 7 0.0003
651 ANGINA PECTORIS 10 0.0003
652 LUNG DISORDER 17 0.0003
653 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
654 METASTASES TO LUNG 4 0.0003
655 ANOSMIA 5 0.0003
656 HYPERTHYROIDISM 5 0.0003
657 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
658 GAIT DISTURBANCE 66 0.0003
659 HYPERTENSION 73 0.0003
660 DYSKINESIA 14 0.0003
661 ELECTROLYTE IMBALANCE 4 0.0003
662 POST PROCEDURAL HAEMORRHAGE 4 0.0003
663 JOINT STIFFNESS 9 0.0003
664 NIGHT SWEATS 11 0.0003
665 RIB FRACTURE 7 0.0003
666 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
667 LYMPHOCYTE COUNT DECREASED 6 0.0003
668 BRADYCARDIA 18 0.0003
669 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
670 DEEP VEIN THROMBOSIS 22 0.0003
671 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
672 WHEEZING 20 0.0003
673 BLOOD IRON DECREASED 4 0.0003
674 PULMONARY EMBOLISM 32 0.0003
675 CARDIAC FAILURE 27 0.0003
676 GALLBLADDER DISORDER 6 0.0003
677 CHOLECYSTITIS 4 0.0003
678 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
679 RENAL IMPAIRMENT 28 0.0003
680 ANXIETY 94 0.0003
681 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
682 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
683 RETCHING 7 0.0003
684 ABNORMAL BEHAVIOUR 13 0.0003
685 DISORIENTATION 13 0.0003
686 DIABETES MELLITUS 25 0.0003
687 DYSPNOEA 185 0.0003
688 TYPE 2 DIABETES MELLITUS 11 0.0003
689 ANAPHYLACTIC REACTION 18 0.0003
690 SKIN CANCER 7 0.0003
691 ANKLE FRACTURE 5 0.0003
692 DECREASED APPETITE 75 0.0003
693 RENAL DISORDER 15 0.0003
694 ILEUS 4 0.0003
695 HEPATIC FUNCTION ABNORMAL 12 0.0003
696 MIDDLE INSOMNIA 6 0.0003
697 PNEUMONIA 104 0.0003
698 TREMOR 53 0.0003
699 CATARACT 19 0.0003
700 HYPOTENSION 64 0.0003
701 INFECTION 46 0.0003
702 MUSCLE ATROPHY 4 0.0003
703 PROTEINURIA 6 0.0003
704 FEELING JITTERY 6 0.0003
705 RED BLOOD CELL COUNT DECREASED 9 0.0003
706 ULCER 5 0.0003
707 PRODUCT USE ISSUE 59 0.0003
708 ABSCESS 5 0.0003
709 OROPHARYNGEAL PAIN 29 0.0003
710 AGITATION 23 0.0003
711 HEART RATE INCREASED 31 0.0003
712 PULMONARY FIBROSIS 6 0.0003
713 CHEST DISCOMFORT 32 0.0003
714 POST PROCEDURAL COMPLICATION 6 0.0003
715 GLAUCOMA 6 0.0003
716 ANOREXIA 4 0.0003
717 PRESCRIBED OVERDOSE 6 0.0003
718 UNRESPONSIVE TO STIMULI 8 0.0003
719 DIZZINESS 154 0.0003
720 ASTHENIA 116 0.0003
721 DEPRESSION 70 0.0003
722 CHOKING 6 0.0003
723 DEAFNESS 8 0.0003
724 ECZEMA 16 0.0003
725 EMOTIONAL DISTRESS 37 0.0003
726 MUSCULOSKELETAL PAIN 16 0.0003
727 NEPHROLITHIASIS 14 0.0003
728 LABORATORY TEST ABNORMAL 9 0.0003
729 CHOLELITHIASIS 10 0.0003
730 WEIGHT DECREASED 85 0.0003
731 ABDOMINAL DISCOMFORT 51 0.0003
732 GASTRITIS 8 0.0003
733 SINUS DISORDER 6 0.0003
734 CARDIAC ARREST 25 0.0003
735 DYSMENORRHOEA 4 0.0003
736 UPPER LIMB FRACTURE 6 0.0003
737 RESPIRATORY DISORDER 9 0.0003
738 DRY EYE 15 0.0003
739 LEUKOPENIA 15 0.0003
740 EYE HAEMORRHAGE 4 0.0003
741 PALPITATIONS 35 0.0003
742 CORONARY ARTERY DISEASE 9 0.0003
743 NAUSEA 235 0.0003
744 INJURY ASSOCIATED WITH DEVICE 6 0.0003
745 DRUG ADMINISTRATION ERROR 9 0.0003
746 MOBILITY DECREASED 21 0.0003
747 EMOTIONAL DISORDER 9 0.0003
748 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
749 GASTRIC DISORDER 10 0.0003
750 APPLICATION SITE RASH 4 0.0003
751 NIGHTMARE 10 0.0003
752 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
753 OFF LABEL USE 251 0.0003
754 LOCAL SWELLING 5 0.0003
755 APHONIA 4 0.0003
756 CEREBRAL INFARCTION 7 0.0003
757 VOMITING 134 0.0003
758 BLOOD TEST ABNORMAL 4 0.0003
759 METASTASES TO LIVER 5 0.0003
760 FEELING ABNORMAL 68 0.0003
761 COLD SWEAT 5 0.0003
762 MUSCLE SPASMS 52 0.0003
763 LYMPHOPENIA 4 0.0003
764 HEAD DISCOMFORT 5 0.0003
765 BRONCHOSPASM 4 0.0003
766 HYPERSOMNIA 8 0.0003
767 GOUT 5 0.0003
768 ACCIDENTAL UNDERDOSE 4 0.0003
769 PRODUCT SUBSTITUTION ISSUE 16 0.0003
770 DEVICE DISLOCATION 12 0.0003
771 MENTAL DISORDER 12 0.0003
772 CARDIOVASCULAR DISORDER 7 0.0003
773 TREATMENT NONCOMPLIANCE 15 0.0003
774 DYSSTASIA 8 0.0003
775 RESTLESSNESS 10 0.0003
776 PRODUCTIVE COUGH 13 0.0003
777 ANAPHYLACTIC SHOCK 7 0.0003
778 VIRAL INFECTION 9 0.0003
779 RESPIRATORY TRACT INFECTION 7 0.0003
780 HYPOGLYCAEMIA 13 0.0003
781 RASH PAPULAR 6 0.0003
782 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
783 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
784 PERIPHERAL SWELLING 41 0.0003
785 HEPATIC CIRRHOSIS 5 0.0003
786 DYSARTHRIA 10 0.0003
787 SKIN BURNING SENSATION 19 0.0003
788 MYALGIA 45 0.0003
789 FLATULENCE 15 0.0003
790 ILL-DEFINED DISORDER 16 0.0003
791 CARDIO-RESPIRATORY ARREST 11 0.0003
792 INCREASED APPETITE 5 0.0003
793 BLOOD PRESSURE INCREASED 40 0.0003
794 INSURANCE ISSUE 4 0.0003
795 MENSTRUATION IRREGULAR 7 0.0003
796 THROMBOSIS 21 0.0003
797 FEAR 7 0.0003
798 RASH MACULAR 9 0.0003
799 NEUTROPENIA 35 0.0003
800 EAR PAIN 5 0.0003
801 HYPERKALAEMIA 9 0.0003
802 KIDNEY INFECTION 5 0.0003
803 SOMNOLENCE 51 0.0003
804 OCULAR HYPERAEMIA 12 0.0003
805 HEAD INJURY 8 0.0003
806 COMA 12 0.0003
807 PRODUCT QUALITY ISSUE 34 0.0003
808 DIABETIC KETOACIDOSIS 6 0.0002
809 LOSS OF CONSCIOUSNESS 32 0.0002
810 HIP FRACTURE 8 0.0002
811 LIVER DISORDER 11 0.0002
812 PARAESTHESIA 39 0.0002
813 PAIN IN EXTREMITY 73 0.0002
814 DRY SKIN 33 0.0002
815 TASTE DISORDER 5 0.0002
816 FALL 82 0.0002
817 VERTIGO 15 0.0002
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
819 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
820 ARTHRITIS 19 0.0002
821 BLOOD PRESSURE DECREASED 16 0.0002
822 AGEUSIA 6 0.0002
823 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
824 ROAD TRAFFIC ACCIDENT 10 0.0002
825 DYSPNOEA EXERTIONAL 9 0.0002
826 HALLUCINATION 18 0.0002
827 HOT FLUSH 18 0.0002
828 ASCITES 7 0.0002
829 COLITIS 9 0.0002
830 MALAISE 104 0.0002
831 HALLUCINATION, VISUAL 5 0.0002
832 FLUID RETENTION 12 0.0002
833 SINUSITIS 24 0.0002
834 LIVER FUNCTION TEST INCREASED 5 0.0002
835 HYPERHIDROSIS 30 0.0002
836 IRRITABILITY 14 0.0002
837 MUSCULOSKELETAL DISCOMFORT 4 0.0002
838 DIPLOPIA 6 0.0002
839 FAECES DISCOLOURED 5 0.0002
840 BLOOD GLUCOSE DECREASED 11 0.0002
841 TRANSAMINASES INCREASED 5 0.0002
842 CARDIAC DISORDER 21 0.0002
843 NERVOUS SYSTEM DISORDER 7 0.0002
844 ISCHAEMIC STROKE 4 0.0002
845 HEADACHE 140 0.0002
846 THERAPY NON-RESPONDER 10 0.0002
847 HOSPITALISATION 34 0.0002
848 HEART RATE IRREGULAR 5 0.0002
849 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
850 C-REACTIVE PROTEIN INCREASED 8 0.0002
851 HYPOTHYROIDISM 7 0.0002
852 MOVEMENT DISORDER 7 0.0002
853 RESPIRATORY ARREST 6 0.0002
854 ARTHRALGIA 90 0.0002
855 PROCEDURAL PAIN 6 0.0002
856 INFLUENZA 24 0.0002
857 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
858 BACTERIAL INFECTION 4 0.0002
859 EYE DISORDER 7 0.0002
860 CEREBROVASCULAR ACCIDENT 36 0.0002
861 ASTHMA 24 0.0002
862 FEELING HOT 13 0.0002
863 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
864 MEMORY IMPAIRMENT 29 0.0002
865 MIGRAINE 20 0.0002
866 BALANCE DISORDER 18 0.0002
867 HERNIA 4 0.0002
868 MENTAL IMPAIRMENT 5 0.0002
869 NEURALGIA 5 0.0002
870 FATIGUE 160 0.0002
871 PLASMA CELL MYELOMA 8 0.0002
872 LIVER INJURY 5 0.0002
873 DISEASE PROGRESSION 24 0.0002
874 DISABILITY 4 0.0002
875 OSTEONECROSIS OF JAW 5 0.0002
876 BLOOD GLUCOSE INCREASED 38 0.0002
877 EXTRAPYRAMIDAL DISORDER 5 0.0002
878 RHINORRHOEA 13 0.0002
879 AMNESIA 13 0.0002
880 HAEMATOCHEZIA 11 0.0002
881 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
882 LACRIMATION INCREASED 6 0.0002
883 FEEDING DISORDER 4 0.0002
884 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
885 BODY TEMPERATURE INCREASED 4 0.0002
886 TINNITUS 9 0.0002
887 EYE PAIN 11 0.0002
888 INFLUENZA LIKE ILLNESS 16 0.0002
889 CHEST PAIN 36 0.0002
890 INFLAMMATION 10 0.0002
891 HYPOAESTHESIA 29 0.0002
892 DYSPEPSIA 19 0.0002
893 PANIC ATTACK 7 0.0002
894 RHABDOMYOLYSIS 8 0.0002
895 VISION BLURRED 26 0.0002
896 COUGH 53 0.0002
897 MOOD SWINGS 6 0.0002
898 COVID-19 33 0.0002
899 EATING DISORDER 4 0.0002
900 JOINT INJURY 4 0.0002
901 NASAL CONGESTION 11 0.0002
902 FREQUENT BOWEL MOVEMENTS 5 0.0002
903 PRODUCT DISPENSING ERROR 4 0.0002
904 ARTHROPATHY 10 0.0002
905 EYE PRURITUS 6 0.0002
906 TARDIVE DYSKINESIA 5 0.0002
907 PRODUCT AVAILABILITY ISSUE 4 0.0002
908 DYSGEUSIA 13 0.0002
909 SUICIDAL IDEATION 16 0.0002
910 EYE IRRITATION 10 0.0002
911 ADVERSE EVENT 16 0.0002
912 NEOPLASM PROGRESSION 6 0.0002
913 BONE PAIN 10 0.0002
914 ACUTE MYOCARDIAL INFARCTION 5 0.0002
915 ARRHYTHMIA 8 0.0002
916 HEPATIC FAILURE 5 0.0002
917 LOCALISED INFECTION 4 0.0002
918 ALOPECIA 32 0.0002
919 HYPOACUSIS 7 0.0002
920 BRONCHITIS 12 0.0002
921 LIMB DISCOMFORT 5 0.0002
922 NECK PAIN 9 0.0002
923 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
924 INCORRECT DOSE ADMINISTERED 36 0.0002
925 WEIGHT INCREASED 35 0.0002
926 DEVICE ISSUE 14 0.0002
927 LACTIC ACIDOSIS 5 0.0002
928 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
929 DYSPHONIA 9 0.0002
930 NERVOUSNESS 8 0.0002
931 PRODUCT DOSE OMISSION ISSUE 45 0.0002
932 IMPAIRED HEALING 5 0.0002
933 VISUAL ACUITY REDUCED 5 0.0002
934 MUSCULOSKELETAL STIFFNESS 13 0.0001
935 DISTURBANCE IN ATTENTION 8 0.0001
936 LIMB INJURY 4 0.0001
937 DISEASE RECURRENCE 7 0.0001
938 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
939 ILLNESS 15 0.0001
940 DRUG DOSE OMISSION 24 0.0001
941 GASTROINTESTINAL DISORDER 13 0.0001
942 OVERDOSE 31 0.0001
943 NASOPHARYNGITIS 26 0.0001
944 PANCREATIC CARCINOMA 4 0.0001
945 FLUSHING 14 0.0001
946 SURGERY 8 0.0001
947 THERAPY CESSATION 7 0.0001
948 PSYCHOTIC DISORDER 4 0.0001
949 INTESTINAL OBSTRUCTION 5 0.0001
950 THERAPEUTIC RESPONSE DECREASED 8 0.0001
951 NO ADVERSE EVENT 23 0.0001
952 METABOLIC ACIDOSIS 4 0.0001
953 JOINT SWELLING 15 0.0001
954 VISUAL IMPAIRMENT 15 0.0001
955 INFUSION RELATED REACTION 8 0.0001
956 AGGRESSION 6 0.0001
957 NEOPLASM MALIGNANT 8 0.0001
958 ANGER 4 0.0001
959 DEVICE LEAKAGE 5 0.0001
960 DEVICE USE ERROR 4 0.0001
961 PSORIASIS 15 0.0001
962 HEART RATE DECREASED 4 0.0001
963 DRUG INTOLERANCE 11 0.0001
964 DEPRESSED MOOD 6 0.0001
965 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
966 THROAT IRRITATION 5 0.0001
967 INJECTION SITE MASS 4 0.0001
968 BLOOD CHOLESTEROL INCREASED 5 0.0001
969 DEATH 90 0.0001
970 TOXICITY TO VARIOUS AGENTS 17 0.0001
971 SUICIDE ATTEMPT 6 0.0001
972 EXTRA DOSE ADMINISTERED 4 0.0001
973 PSORIATIC ARTHROPATHY 4 0.0001
974 BLINDNESS 4 0.0001
975 THERAPY INTERRUPTED 7 0.0001
976 DERMATITIS ATOPIC 5 0.0001
977 PANCREATITIS 5 0.0001
978 ACNE 7 0.0001
979 PRODUCT DOSE OMISSION 6 0.0001
980 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
981 DEVICE MALFUNCTION 6 0.0001
982 DRUG DEPENDENCE 13 0.0001
983 RHEUMATOID ARTHRITIS 9 0.0001
984 INJECTION SITE HAEMORRHAGE 6 0.0001
985 TREATMENT FAILURE 6 0.0001
986 COMPLETED SUICIDE 6 0.0001
987 INTENTIONAL OVERDOSE 4 0.0001
988 MYOCARDIAL INFARCTION 10 0.0001
989 INJECTION SITE PAIN 17 0.0001
990 INJECTION SITE ERYTHEMA 6 0.0000
991 DRUG WITHDRAWAL SYNDROME 4 0.0000
992 BREAST CANCER 4 0.0000